AR213102A1 - Procedimiento para obtener compuestos de espiro(1,3-dioxalan-4,3')quinuclidina y sus sales - Google Patents

Procedimiento para obtener compuestos de espiro(1,3-dioxalan-4,3')quinuclidina y sus sales

Info

Publication number
AR213102A1
AR213102A1 AR265266A AR26526676A AR213102A1 AR 213102 A1 AR213102 A1 AR 213102A1 AR 265266 A AR265266 A AR 265266A AR 26526676 A AR26526676 A AR 26526676A AR 213102 A1 AR213102 A1 AR 213102A1
Authority
AR
Argentina
Prior art keywords
dioxalan
quinuclidine
salts
procedure
spiro compounds
Prior art date
Application number
AR265266A
Other languages
English (en)
Spanish (es)
Original Assignee
Purdue Frederick Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Frederick Co filed Critical Purdue Frederick Co
Application granted granted Critical
Publication of AR213102A1 publication Critical patent/AR213102A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR265266A 1975-11-11 1976-10-28 Procedimiento para obtener compuestos de espiro(1,3-dioxalan-4,3')quinuclidina y sus sales AR213102A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL48452A IL48452A (en) 1975-11-11 1975-11-11 Spiro (1,3-dioxolane-4,3') quinuclidines,their preparationand pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
AR213102A1 true AR213102A1 (es) 1978-12-15

Family

ID=11048545

Family Applications (2)

Application Number Title Priority Date Filing Date
AR265266A AR213102A1 (es) 1975-11-11 1976-10-28 Procedimiento para obtener compuestos de espiro(1,3-dioxalan-4,3')quinuclidina y sus sales
AR270024A AR214652A1 (es) 1975-11-11 1977-11-18 Procedimiento para obtener compuestos de espiro(1,3-dioxolan-4,3')quinuclidina y sus sales

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR270024A AR214652A1 (es) 1975-11-11 1977-11-18 Procedimiento para obtener compuestos de espiro(1,3-dioxolan-4,3')quinuclidina y sus sales

Country Status (20)

Country Link
US (1) US4104397A (da)
JP (1) JPS5277092A (da)
AR (2) AR213102A1 (da)
AT (1) AT356652B (da)
AU (1) AU507660B2 (da)
BE (1) BE848228A (da)
CA (1) CA1071629A (da)
CH (1) CH626085A5 (da)
DE (1) DE2650845A1 (da)
DK (1) DK148744C (da)
ES (2) ES453161A1 (da)
FI (1) FI60015C (da)
FR (1) FR2331343A1 (da)
GB (1) GB1542494A (da)
IL (1) IL48452A (da)
MX (1) MX4395E (da)
NL (1) NL7612426A (da)
NO (1) NO145618C (da)
NZ (1) NZ182555A (da)
ZA (1) ZA766662B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454056A1 (fr) * 1979-03-15 1980-11-07 Geissmann Robert Cheminee cinetique pouvant etre utilisee comme rotissoire
EP0189370A3 (de) * 1985-01-16 1988-01-27 Sandoz Ag Spiro-dioxolane, -dithiolane und -oxothiolane
JPS61167130A (ja) * 1985-01-17 1986-07-28 Nissan Motor Co Ltd 内燃機関の吸気装置
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
ES2074441T3 (es) * 1987-10-05 1995-09-16 Yamanouchi Pharma Co Ltd Compuestos espiro heterociclicos y su preparacion.
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
JPH01164409A (ja) * 1987-12-18 1989-06-28 Nippon Paint Co Ltd 浄化装置
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
GB8816299D0 (en) * 1988-07-08 1988-08-10 Merck Sharp & Dohme Therapeutic agents
US5407938A (en) * 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
EP0984970B1 (en) 1997-05-30 2003-11-19 Neurosearch A/S Spiro-quinuclidine derivatives, their preparation and use
JP4564135B2 (ja) * 1999-07-26 2010-10-20 住友化学株式会社 高純度フェノチアジン化合物とその製造方法、およびその中間体の製造方法、並びにその中間体の原料の水和物と新規結晶
WO2008073067A1 (en) * 2006-08-02 2008-06-19 Janssen Pharmaceutica N.V. Novel spiro-quinuclidinyl derivatives for the treatment of the central nervous system disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681363A (en) * 1970-08-20 1972-08-01 Univ Temple Spiro(imidazolidine-4,3{40 -quinuclidine)-2,5-diones

Also Published As

Publication number Publication date
AU1955476A (en) 1978-05-18
FI60015C (fi) 1981-11-10
IL48452A (en) 1979-07-25
DK148744C (da) 1986-02-03
NO145618C (no) 1982-04-28
GB1542494A (en) 1979-03-21
US4104397A (en) 1978-08-01
DE2650845A1 (de) 1977-05-18
AT356652B (de) 1980-05-12
AR214652A1 (es) 1979-07-13
FI60015B (fi) 1981-07-31
NO763819L (da) 1977-05-12
NZ182555A (en) 1979-01-11
ATA839376A (de) 1979-10-15
AU507660B2 (en) 1980-02-21
IL48452A0 (en) 1976-01-30
CH626085A5 (da) 1981-10-30
DK507276A (da) 1977-05-12
NO145618B (no) 1982-01-18
NL7612426A (nl) 1977-05-13
JPS5277092A (en) 1977-06-29
ZA766662B (en) 1977-10-26
FI763151A (da) 1977-05-12
MX4395E (es) 1982-04-23
ES453161A1 (es) 1977-11-01
BE848228A (fr) 1977-03-01
JPS6259113B2 (da) 1987-12-09
CA1071629A (en) 1980-02-12
FR2331343B1 (da) 1980-04-04
DK148744B (da) 1985-09-16
ES460286A1 (es) 1978-04-01
FR2331343A1 (fr) 1977-06-10

Similar Documents

Publication Publication Date Title
AR210909A1 (es) Procedimiento para producir microcapsulas de poliurea
MX4502E (es) Procedimiento para preparar 9alfa-hidroxiandrostenodiona
AR215134A1 (es) Procedimiento para preparar nuevas 1-amidino-3-fenilureas
MX4047E (es) Procedimiento para preparar aralquilimidazoles
AR215584A1 (es) Procedimiento para preparar fenilamidinoureas
MX3638E (es) Procedimiento para preparar metilpirazolilamidas
SE406046B (sv) Applikatorhuvud for festorgan
MX3654E (es) Procedimiento para preparar compuestos de sulfonilbencimidazol
MX3972E (es) Procedimiento para preparar compuestos de 2-aroil-3-fenilbenzotiofeno
AR213102A1 (es) Procedimiento para obtener compuestos de espiro(1,3-dioxalan-4,3')quinuclidina y sus sales
DK145674C (da) Barbermaskinehoved
MX3737E (es) Procedimiento para preparar compuestos de rifamacina
AR213168A1 (es) Procedimiento para obtener nuevas tricloracetamidinas sustituidas
MX143361A (es) Procedimiento para preparacion de azinas
DK521476A (da) Engangssprojte
MX3832E (es) Procedimiento para preparar pirazolinonas
MX4858E (es) Procedimiento para preparar compuestos de bis-carbamilguanidino-aza-alcano
AR213184A1 (es) Procedimiento para preparar derivados de 1,4-etan-6-oxo-perhidroquinoleina y sus sales
MX143905A (es) Procedimiento para la preparacion de sales de 4-amino bencendiazonio
NO146164C (no) Varmefoelsomme latekser
AR216058A1 (es) Procedimiento de preparacion de sulfoximidas sustituidas,y sus sales
MX3513E (es) Procedimiento para preparar compuestos de formamidosulfenilanina
DK142728C (da) Tovslaaningshoved
AR210360A1 (es) Procedimiento para producir fortimicina c.
MX4291E (es) Procedimiento para preparar compuestos de aroil-fenilnaftaleno